Advertisement Ricerca Biosciences appoints new scientist for Drug Safety division - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Ricerca Biosciences appoints new scientist for Drug Safety division

Ricerca Biosciences, a preclinical contract research organisation (CRO) providing services to the biopharmaceutical industry, has appointed Eric Lubert as a scientist in its Drug Safety division.

In his role Lubert will be responsible for the technical management of Ricerca’s biotherapeutics assay group and scientific leadership in biotherapeutic development programs.

Moreover, his team will assist with the expansion of Ricerca’s current capabilities to provide development services for protein, peptide, siRNA therapeutics, and both prophylactic and therapeutic vaccines.

Prior to joining Ricerca, Lubert was a research scientist at Battelle Memorial Research Institute where he was responsible for coordinating and advancing select agent detection capabilities.